NV03 是一种有效，选择性的UHRF1与H3K9me3相互作用的小分子拮抗剂，Kd值为 2.4 μM。NV03 具有抗癌活性。

NV03 is a potent and selective antagonist of UHRF1 (Ubiquitin-like with PHD and RING finger domains 1)- H3K9me3 interaction by binding to UHRF1 tandem tudor domain, with a K d of 2.4 μM. NV03 is a possible application as anticancer therapeutics [1].

2448341-58-8

C19H27N5O2S

389.51

NV03

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years